Request for Applications: Patient-Partnered Rare Neurodegenerative Disease RFA
CZI Science Logo ([link removed] )
Image of neuron ([link removed] )
Request for Applications: Patient-Partnered Rare Neurodegenerative Disease RFA
Applications due May 24, 2022 by 5 p.m. Pacific Time
Apply Now
([link removed] )
The application deadline for the Patient-Partnered Collaborations for Rare Neurodegenerative Disease RFA ([link removed] ) is approaching.
This RFA invites applications from collaborative teams bringing together patient-led rare disease organizations and research teams for 4-year research projects aimed at advancing our understanding of the fundamental science of rare diseases. It aims to advance the understanding of the pathophysiology and mechanistic underpinnings of rare neurodegenerative and neurological disorders.
The awards cover $2 million in total costs for four years for each project, distributed among research institutions and a patient organization. Applications are due May 24, 2022 at 5 p.m. Pacific Time. Full details here ([link removed] ) .
For questions about the grant opportunity, email
[email protected] (mailto:
[email protected]) .
Apply to Attend the Networking Expo
CZI is organizing an ideation and matchmaking workshop designed to bring together researchers and patient-advocates/organizations looking to develop a new collaboration, expand their collaborative team, and/or connect around potential projects for this RFA.
The event will be held on Wednesday, April 20, from 9am-3pm Pacific Time. Applications will be approved on a rolling basis, and the deadline has been extended to April 15, 5pm Pacific Time. Learn more and apply ([link removed] ) .
For questions about the Networking Expo, email our partners at KnowInnovation at
[email protected] (mailto:
[email protected]) .
Facebook ([link removed] )
Twitter ([link removed] )
Instagram ([link removed] )
LinkedIn ([link removed] )
YouTube ([link removed] )
©2022 CZI Foundation | P.O. Box 8040, Redwood City, CA 94063
Manage Preferences ([link removed] ) | Unsubscribe from All ([link removed] )